共 50 条
- [1] Suggested limits for high and low neutralising antibody levels in interferon-beta treated multiple sclerosis patients MULTIPLE SCLEROSIS, 2006, 12 : S204 - S204
- [2] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
- [4] Persistent neutralising antibodies to interferon-beta and clinical outcomes in multiple sclerosis patients MULTIPLE SCLEROSIS, 2006, 12 : S205 - S205
- [7] NEUTRALISING ANTIBODIES TO INTERFERON-BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
- [9] Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis LANCET NEUROLOGY, 2010, 9 (07): : 740 - 750